Every month, we present an outstanding company that stands out through innovation, commitment, and excellent service. For the month of November, we are delighted to feature Cardio Center Luzern AG as our SME of the Month. This medical center, located in the heart of Lucerne, specializes in the treatment of heart and circulatory diseases, offering its patients state-of-the-art care and comprehensive support.
"Cardio Center Luzern AG is a leading medical center for heart and circulatory diseases in central Switzerland. Equipped with advanced diagnostic technology and an experienced team, it provides specialized treatments in cardiology. Patients benefit from comprehensive care that meets the latest scientific standards. A unique advantage is the walk-in service: without needing an appointment, patients with acute issues can be examined and treated on the spot. The center places great value on individualized therapy approaches and collaborates closely with other departments and hospitals to ensure the best possible care."
In our Flash Talk with Dr. Cuculi, we had the opportunity to discuss the importance of a healthy lifestyle for heart health. He emphasized that a healthy heart "gives us the rhythm of life" and highlighted the importance of motivating seniors to stay active. With the right balance of healthy eating, regular exercise, and a moderate lifestyle, many people can achieve old age with a high quality of life. "Balance is key," emphasized Dr. Cuculi, explaining that the goal is not to take extreme measures but rather to embrace a balanced way of life.
Take a look at our full Flash Talk with Prof. Dr. med. Florim Cuculi here:
Cardio Center Luzern AG impressively demonstrates what modern healthcare can look like: patient-centered, scientifically grounded, and always at the cutting edge of research. We are pleased to present this inspiring company as our SME of the Month for November.
Der Schweizer Finanzplatz steht nach der Übernahme der Credit Suisse durch die UBS vor einem tiefgreifenden Wandel, der insbesondere Schweizer Unternehmen und vor allem KMUs – das Rückgrat der Schweizer Wirtschaft – betrifft. Diese Analyse beleuchtet die Strategie der neuen UBS, ihre Auswirkungen auf das Firmenkundengeschäft und die Chancen für andere Marktteilnehmer, die entstandene Lücke zu schliessen. Zudem wird der Handlungsbedarf für Schweizer Unternehmen aufgezeigt.
